Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年2月5日
	新闻
	High-Plasticity Cell State Drives Lung Cancer Progression and Drug Resistance AACR Journals Ablation of HPCS cells blocked benign-to-malignant progression in early lesions and reduced tumor burden in established lung adenocarcinomas, ... 标记为不相关
	Biomarkers in Lung Cancer Immunotherapy: A Bibliometric and Visualization Analysis of ... Oncodaily Immunotherapy has fundamentally transformed the treatment landscape of lung cancer, particularly through immune checkpoint inhibitors (ICIs) ... 标记为不相关
	Lung Cancer Guidelines India: Standardizing Care and Palliation - OC Academy OC Academy India releases its first national, evidence-based lung cancer guidelines India to standardize treatment, improve early diagnosis, ... 标记为不相关
	WHO Analysis Finds Many Global Cancer Cases Attributable to Modifiable Risk Factors The ASCO Post Collectively, lung, stomach, and cervical cancers accounted for almost half of all preventable cancers—lung cancer was mostly linked with smoking and ... 标记为不相关
	High Ultra-Processed Food Intake Linked to Lung Cancer Risk - Medscape Medscape Dr Maurie Markman discusses a recent study reporting a distinct association between high consumption of ultra-processed foods and lung cancer ... 标记为不相关
	Cancer Programs News: February 5 | ACS - American College of Surgeons American College of Surgeons The session will provide an update on the implementation of the six surgical standards in melanoma and breast, colon, rectum, and lung cancers at CoC- ... 标记为不相关
	Patient-centric oncology trials - PharmaTimes PharmaTimes Seeing it take centre stage in our work at Takeda makes me incredibly proud. One endeavour that has brought this to life is the Not All Lung Cancers ... 标记为不相关
	Strengthening Clinical Trial Communication: Karmanos and McLaren Launch First Joint ... McLaren Health Care ... oncology and non-oncology research sites. The project, Ask Questions ... Catching Lung Cancer Early Could Save Your Life. McLaren Northern ... 标记为不相关
	Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 ... PR Newswire ... lung cancer (ES-SCLC), non-squamous non-small cell lung cancer (nsNSCLC), and esophageal squamous cell carcinoma (ESCC). In the EU, it has been ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈